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Abstract
Background Increased oxidative stress and changes in antioxidant capacity
observed in both clinical and experimental diabetes mellitus have been
implicated in the etiology of chronic diabetic complications. Many authors
have shown that hyperglycemia leads to an increase in lipid peroxidation in
diabetic patients and animals reflecting a rise in reactive oxygen species
production. The aim of the study was to compare the susceptibility of
mitochondria from brain and liver of Goto-Kakizaki (12-month-old diabetic)
rats (GK rats), a model of non-insulin dependent diabetes mellitus, to
oxidative stress and antioxidant defenses.
Methods Brain and liver mitochondrial preparations were obtained by
differential centrifugation. Oxidative damage injury was induced in vitro by
the oxidant pair ADP/Fe2+ and the extent of membrane oxidation was
assessed by oxygen consumption, malondialdehyde (MDA) and thiobarbituric
acid reactive substances (TBARS) formation. Coenzyme Q and a-tocopherol
contents were measured by high-performance liquid chromatography
(HPLC).
Results Brain mitochondria isolated from 12-month-old control rats
displayed a higher susceptibility to lipid peroxidation, as assessed by
oxygen consumption and formation of MDA and TBARS, compared to liver
mitochondria. In GK rats, mitochondria isolated from brain were more
susceptible to in vitro oxidative damage than brain mitochondria from normal
rats. In contrast, liver mitochondria from diabetic rats were less susceptible to
oxidative damage than mitochondria from normal rats. This decreased
susceptibility was inversely related to their a-tocopherol and coenzyme Q
(CoQ) content.
Conclusions The present results indicate that the diabetic state can result in
an elevation of both a-tocopherol and CoQ content in liver, which may be
involved in the elimination of mitochondrially generated reactive oxygen
species. The difference in the antioxidant defense mechanisms in the brain
and liver mitochondrial preparations of moderately hyperglycemic diabetic
GK rats may correspond to a different adaptive response of the cells to the
increased oxidative damage in diabetes. Copyright # 2001 John Wiley &
Sons, Ltd.
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Introduction
Diabetes is associated with an increased production of
reactive oxygen species (ROS) in both humans and
animals. Enhanced oxidative stress and changes in
antioxidant capacity are considered to play an important
role in the pathogenesis of chronic diabetic complications
[1–4]. Evidence indicates that free oxygen radicals and
membrane lipid peroxidation are significantly increased
in diabetic patients and in rats used as models of diabetes
[5–7]. Glucose autoxidation and non-enzymatic glycation
of proteins are an important source of oxidative species,
which may attack cellular components including nucleic
acids, proteins and membrane lipids thus promoting
cellular damage [3]. A decrease in the endogenous ROS
scavenging compounds that normally protect cells from
oxidative insults has also been observed in diabetic
patients and animals [8,9].
Evidence associating diabetic pathology to mitochon-
drial dysfunction and oxidative stress has been reported
previously [10–14]. Mitochondria are generally consid-
ered to be the major endogenous source of cellular ROS,
under normal and pathological conditions, and perhaps of
oxidative stress in general [15–17]. It has been estimated
that during normal metabolism 1–2% of the electrons
that flow into the redox chain catalyze the incom-
plete reduction of O2 generating superoxide anion and
hydrogen peroxide. Under normal physiological condi-
tions mitochondrial antioxidant systems (enzymatic and
non-enzymatic) scavenge free radicals and preserve mito-
chondrial integrity [18]. Moreover, under certain patho-
physiological conditions the generation of superoxide
radical/hydrogen peroxide dramatically increases, lead-
ing to an imbalance between the pro-oxidant factors and
the antioxidant systems. Since mitochondria are a major
site of ROS generation and have a high concentration of
heme and non-heme iron bound to proteins in addition to
nucleotide–iron and carboxylic acid–iron complexes that
can participate in Haber–Weiss reactions, the mitochon-
drial membrane is a primary target for ROS-induced
damage [18]. The high content of polyunsaturated fatty
acids in mitochondrial membranes enhances mitochon-
drial susceptibility to lipid peroxidation, leading to
membrane dysfunction and alterations in the structural
and functional integrity of the membrane [19]. As brain
and liver heavily depend on mitochondrial oxidative
catabolism for the majority of their ATP requirements,
elevated levels of ROS are particularly dangerous because
they mediate mitochondrial damage, which in turn can
generate further oxidative stress in the cells [20].
The Goto-Kakizaki (GK) rat represents a non-obese
animal model of type 2 diabetes [21] which was obtained
by selective breeding of normal Wistar rats, using glucose
intolerance as the selection index [22,23]. This genetic
model is particularly relevant to understanding human
type 2 diabetes since moderate but stable fasting
hyperglycemia has been demonstrated as early as 2–4
weeks after birth, which does not progress to the ketotic
state. Therefore, in the initial stages of diabetes GK rats do
not present severe complications associated with the
disease, and are thus an appropriate model in which to
study the events at the onset of diabetes, as compared to
obese diabetic rats which present severe hyperglycemia
and hyperlipidemia [21].
There is currently considerable interest in the role of
vitamin E and coenzyme Q (CoQ) compounds in the
protection of membrane lipids against oxidative stress.
CoQ is present in membranes with a-tocopherols [24] and
has been recognized as an important antioxidant in the
inner mitochondrial membrane, where it scavenges
radicals directly and/or regenerates a-tocopherol from
the a-tocopheroxyl radical [25,26]. The possibility that
CoQ content may be one of the factors controlling the
susceptibility of mitochondria to oxidative stress in
diabetic GK rats was examined. Data from our previous
experiments have suggested that GK rats might develop
enhanced defense systems against oxidative stress, which
is believed to be an important factor in the development
of diabetic complications [27]. The ADP/Fe2+ was used
to induce oxidative damage injury in isolated mitochon-
drial preparations and the extent of membrane oxidation
was assessed by oxygen consumption, malondialdehyde
(MDA) and thiobarbituric acid (TBA) reactive species
formation. Furthermore, a-tocopherol and CoQ (CoQ9
and CoQ10) contents were determined and studies were
conducted to compare liver and brain mitochondrial
susceptibility to oxidative stress and antioxidant defenses
in both GK and Wistar rats.
Materials and methods
Animals
Male spontaneously diabetic GK rats (46–54 weeks of
age; body weights 384.7t2.4 g; non-fasting blood
glucose levels 198.6t13.5 mg/dl) were obtained from
a local breeding colony of Coimbra, established in 1995
with breeding couples from the colony at the Tohoku
University School of Medicine (Sendai, Japan; courtesy of
Dr K. I. Susuki). Control animals were non-diabetic male
Wistar rats of similar age (44–53 weeks of age; body
weights 672.5t60.5 g; non-fasting blood glucose levels
93.4t2.9 mg/dl) obtained from our local colony. Ani-
mals were kept under controlled light and humidity
conditions, and with free access to powdered rodent chow
(diet CRF 20; Charles Rivers, France) and water. The
animals were killed by decapitation and their livers and
brains removed and washed in the respective homo-
genization medium.
Materials
Ubiquinone 10 was obtained from Fluka and ubiquinone
9 and a-tocopherol were obtained from Sigma Chemical
Co. (St Louis, MO, USA). All other chemicals used were of
analytical grade.
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Mitochondrial preparations
Liver mitochondria were isolated according to a pre-
viously established method [28] with some modifications
[29]. Homogenization medium contained 0.25 mM
sucrose, 5 mM Hepes (pH 7.4) 0.2 mM EGTA, 0.1 mM
EDTA and 0.1% de-fated bovine serum albumin (BSA).
EGTA, EDTA and BSA were omitted from the final
washing medium, adjusted to pH 7.2. The mitochondrial
pellet was washed twice and suspended in washing
medium.
Brain mitochondria (crude mitochondrial preparation)
were isolated using the method of Lai and Clark [30]. All
homogenization and centrifugation steps were performed
in isolation medium (0.32 mM sucrose, 1 mM K+-EDTA,
5 mM Hepes-Tris, pH 7.4). After isolation, the mitochon-
drial suspensions of liver and brain were used after a
30 min recovery and within 4 h of preparation.
Mitochondrial protein was determined by the biuret
method, using BSA as a standard.
Measurement of lipid peroxidation
Lipid peroxidation was determined as described by Sassa
et al. [31]. The oxygen consumption was measured in
1 ml of medium (175 mM KCl, 10 mM Tris-Cl pH 7.4,
supplemented with 3 mM rotenone) containing 1 mg
protein, using a Clark-type electrode (YSI Model 5331;
Yellow Springs Institute) in a glass chamber equipped
with magnetic stirring and a thermostat set at 30uC [32].
Reactions were started by the addition of 1 mM ADP and
0.1 mM FeSO4, after a 2-min incubation period. The
saturated concentration of O2 in the incubation medium
was assumed to be 232 mM at 30uC.
The extent of lipid peroxidation in the brain and liver
mitochondria was also determined by measuring the
amounts of thiobarbituric acid reactive substances
(TBARS) and MDA formed by colorimetric assay and
high-performance liquid chromatography (HPLC),
respectively. The amount of TBARS formed was deter-
mined using the TBA test according to a modified
procedure described by Ernster and Nordenbrand [33].
Mitochondrial protein (1 mg/ml) was incubated at 30uC
for 15 min, in a medium containing 175 mM KCl, 10 mM
Tris-Cl pH 7.4, supplemented with 3 mM rotenone.
Membrane lipid peroxidation was started by adding
simultaneously ADP/FeSO4 (1 mM/0.1 mM). The reac-
tion was stopped by lowering the temperature to 0–4uC by
placing the tubes in ice. To measure lipid peroxidation,
0.5 ml cold 40% trichloroacetic acid and 2 ml 0.67% TBA
containing 6.8 mM 2,6-diterbutyl-4-methylphenol (BHT)
were added to 0.5 ml test material, which was then
heated for 10 min in a boiling water bath and cooled on
ice for 10 min before centrifugation in an Eppendorf
centrifuge (1500 g for 5 min). The supernatants were
collected and the absorbance measured at 535 nm. The
amount of TBARS formed was calculated using a molar
extinction coefficient of 1.56r105 molx1cmx1 and
expressed as nmol TBARS/mg protein [34].
The assay procedure used for MDA determination by
HPLC was that of Wong et al. [35]. Liquid chromato-
graphy was performed using Gilson HPLC apparatus with
a reverse phase column (RP18; Spherisorb; S5 ODS2).
The samples were eluted from the column at a flow rate of
1 ml/min and detection was performed at 532 nm. The
MDA content of the samples was calculated from the
standard curve prepared using the TBA–MDA complex
and expressed in nmol/mg protein.
Extraction and quantification of CoQ
and a-tocopherol
Aliquots of mitochondria containing 1 mg protein/ml
were extracted according to the method described
previously [36]. The extract was evaporated to dryness
under a stream of N2, and suspended in ethanol for HPLC
analysis. Liquid chromatography was performed using
Gilson HPLC apparatus with a reverse phase column
(RP18; Spherisorb; S5 ODS2) as described previously
[37]. Samples were eluted from the column with
methanol : heptane (10 : 2 by volume) at a flow rate of
2 ml/min. Detection was performed using a UV detector
at 269 nm. Identification and quantification were based
on pure standards by their retention times and peak areas,
respectively. The levels of CoQ (CoQ9 and CoQ10) in
mitochondrial membranes were expressed in pmol/mg
protein.
The extraction and separation of a-tocopherol were
performed following the method described by Vatassery
et al. [38]. The extract, evaporated to dryness under a
stream of N2 and kept at –80C, was dissolved in n-hexane
and a-tocopherol content was analyzed by reverse phase
HPLC. A 4.6r200 mm Spherisorb S10w column was
eluted with n-hexane modified with 0.9% methanol, at a
flow rate of 1.5 ml/min. Detection was performed using a
UV detector at 287 nm. The levels of vitamin E in
mitochondrial membranes were expressed in pmol/mg
protein.
Data analysis and statistics
Data are expressed as meanstSEM of the indicated
number of experiments, each obtained with a different
animal. Statistical significance was determined by using
the paired Student’s t-test and by using the one-way
ANOVA Student–Newmann–Keuls post-test for multiple
comparisons. A p value<0.05 was considered significant.
Results
Oxidative stress induced by ADP/Fe2+
Brain mitochondria displayed a higher susceptibility to
lipid peroxidation induced by ADP/Fe2+, as assessed by
oxygen consumption and the formation of TBARS, as
compared to liver mitochondria (Figures 1 and 2). As
shown in Figure 1, the time-dependent change in the
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peroxidation related to oxygen concentrations in the
suspensions of brain and liver mitochondria are different
in preparations isolated from diabetic rats as compared to
control rats. In diabetic mitochondria, at first slow oxygen
consumption occurs for a few minutes after the addition
of ADP/Fe2+ and then the consumption of oxygen
increases. In addition, when mitochondria of GK rats
did begin to peroxidize they did so at a slower rate than
control mitochondria. The time associated with the slow
oxygen consumption that follows the addition of ADP/
Fe2+ until the rapid oxygen uptake (lag time) is
considered to be the time required for the generation of
a sufficient amount of reactive oxygen species derived
from ADP/Fe2+, such as the perferryl complex ADP-Fe3+-
O2
ex responsible for the induction of lipid peroxidation.
The rapid oxygen consumption after the lag phase follows
the peroxidative radical chain proliferation of membrane
lipids by ROS.
Figure 2 shows that in the absence of oxidants the
levels of TBARS were similar in brain and liver
mitochondria isolated from control (1.97t0.31 and
1.33t0.23 nmol/mg protein, respectively) or GK rats
(2.03t0.37 and 1.67t0.36 nmol/mg protein, respec-
tively). In control rats the oxidation by ADP/Fe2+
increased significantly the production of TBARS in
brain and liver to 40.77t2.9 and 16.66t3.36 nmol/mg
protein, respectively. A significant increase in the extent
of oxidation was observed in mitochondria isolated from
the brains of GK rats as compared with mitochondria from
Wistar rats. In contrast, liver mitochondria from diabetic
rats were less susceptible to oxidative damage than
mitochondria from normal rats.
As the validity of the TBA test for the assessment of lipid
peroxidation has been questioned many times [39], the
formation of lipid peroxides (as MDA) was also measured
by a more specific HPLC method. The results obtained
indicated that this procedure yielded lower values of MDA
in control and oxidized mitochondria when compared to
the respective TBARS values (Table 1 and Figure 2). In
Wistar rats, ADP/Fe2+ increased the formation of MDA in
brain and liver to 10.89t0.37 and 11.97t0.17 nmol
MDA/mg protein, respectively, values significantly
different from those determined in control conditions
(1.80t0.35 and 1.14t0.18 nmol MDA/mg protein,
Figure 1. Comparison of ADP/Fe2+-induced mitochondrial O2 consumption in rat brain (A) and liver (B) mitochondria isolated
from Wistar and GK rats. Oxidative stress was induced in mitochondria isolated from the brains or livers of control and dia-
betic rats. Mitochondria (1 mg) were incubated in 1 ml medium consisting of 175 mM KCl, 10 mM Tris (pH 7.4), for 30 min at
30uC, supplemented with 2 mM rotenone. Peroxidation was started by adding 1 mM ADP and 0.1 mM FeSO4. The inserts repre-
sent typical recordings of oxygen consumption. Data are the meanstSEM of seven different experiments. Statistical signifi-
cance: ***p<0.001, **p<0.01 or *p<0.05 as compared to control Wistar rats; {{{p<0.001 as compared to brain mitochondria
Figure 2. Effect of diabetes on the extent of mitochondrial
oxidation induced by ADP/Fe2+. Mitochondria (1 mg) were
incubated in 1 ml medium consisting of 175 mM KCl, 10 mM
Tris (pH 7.4), for 30 min at 30uC, supplemented with 2 mM
rotenone. Peroxidation was started by adding 1 mM ADP and
0.1 mM FeSO4. In controls mitochondria were incubated in
the absence of the oxidizing agents. The extent of synaptoso-
mal oxidation was determined by the TBA method and
expressed as nmol/mg protein. Data are the meanstSEM of
seven experiments run in duplicate. Statistical significance:
***p<0.001 as compared to respective controls not treated
with ADP/Fe2+; {p<0.05 as compared to Wistar mitochondria
treated with ADP/Fe2+; {{{p<0.001 as compared to data
obtained for oxidized brain mitochondria
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respectively). A significant increase in MDA formation
was observed in brain mitochondria isolated from GK rats
submitted to ADP/Fe2+ (12.44t0.40 nmol/mg protein)
as compared with mitochondria from Wistar rats
(10.89t0.39 nmol/mg protein). The levels of MDA in
control and oxidized liver mitochondria from GK rats
(0.44t0.11 and 9.91t0.36 nmol/mg protein, respec-
tively) were lower than those in Wistar mitochon-
dria (1.14t0.18 and 11.97t0.17 nmol/mg protein,
respectively; Table 1).
CoQ and a-tocopherol content in
mitochondria
CoQ in rat mitochondria consisted of two main homo-
logues, CoQ9 and CoQ10. In the brains of control Wistar rats,
CoQ9 represented about 80% and CoQ10 20% of the total
amount of mitochondrial CoQ (1.14t0.07 nmol/mg
protein). In liver mitochondria, CoQ9 constituted about
97% of the total CoQ content (0.89t0.04 nmol/mg
protein). Brain mitochondria of GK and control Wistar
rats contained similar levels of a-tocopherol, but the CoQ9
content in the GK mitochondria was lower than that in the
Wistar mitochondria. In contrast, there was a remarkable
increase of about 100% in the a-tocopherol and CoQ
content in the liver mitochondria isolated from diabetic
rats as compared to control rats (Figures 3 and 4). In
brain and liver the changes in CoQ9 content paralleled
that of the total CoQ content (Figure 4).
Discussion
One of the main findings of the present study was
the observation of differential content of CoQ and
a-tocopherol in mitochondria isolated from diabetic
animals. Thus, diabetes increased the levels of CoQ and
a-tocopherol in liver mitochondria isolated from diabetic
GK rats but not in brain mitochondria. A small decrease in
CoQ content was observed in brain mitochondria. Another
point of interest was the observation that there is an inverse
correlation between the levels of the antioxidants
a-tocopherol and CoQ and the susceptibility of mitochon-
dria to oxidative damage induced by ADP/Fe2+.
Many authors have associated hyperglycemia-induced
changes in oxidative state with diabetic complications.
Evidence for oxidative stress in diabetes includes reports
of increased free radical generated plasma lipid peroxides
and observations of decreased antioxidant plasma con-
centrations in both humans and animal models of
diabetes [7]. Although, the concentrations of vitamin E
in plasma and in tissues, in both diabetic patients and
experimental diabetes, are controversial, an inverse
association between serum a-tocopherol concentration
and subsequent occurrence of the disease has been
Table 1. Levels of MDA in brain and liver mitochondria oxid-
ized with ADP/Fe2+
Experimental condition Brain Liver
Wistar rats
Control 1.80t0.35 1.14t0.18
Oxidized 10.89t0.37*** 11.97t0.17***
GK rats
Control 1.34t0.34 0.44t0.11§
Oxidized 12.44t0.40***{ 9.91t0.36***{{{
The experimental conditions were similar to those described in the legend to
Figure 2. MDA levels were determined by HPLC and were expressed as nmol
MDA/mg protein. Data are the meanstSEM from three different samples,
each obtained from a different rat. Statistical significance: ***p<0.001 as
compared to respective controls not treated with ADP/Fe2+; §p<0.05
as compared to respective Wistar control; {{{p<0.001 and {p<0.05 as
compared to Wistar mitochondria treated with ADP/Fe2+.
Figure 3. Vitamin E levels in brain and liver mitochondria iso-
lated from Wistar and GK rats. Vitamin E (a-tocopherol) was
measured by reverse-phase HPLC as described in Materials
and methods. The data are the meantSEM for seven differ-
ent samples, each obtained from a different rat. Statistical
significance: *p<0.05 as compared to the levels of vitamin E
in control Wistar rats
Figure 4. Coenzyme Q9 and Q10 levels in brain and liver mito-
chondria isolated from Wistar and GK rats. Coenzyme Q
levels were measured by HPLC as described in Materials and
methods. Data are the meanstSEM for seven different sam-
ples, each obtained from a different rat. Statistical signifi-
cance: ***p<0.001 or *p<0.05 as compared to control
Wistar rats; {{{p<0.005 as compared to GK brain mitochon-
dria; {p<0.005 as compared to brain values
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reported [40]. A beneficial effect of vitamin E on the
complications of diabetes was also reported [41–43].
An increase in a-tocopherol might be expected to
render the mitochondria more resistant to in vitro lipid
peroxidation. This is illustrated by the time course
experiments on oxygen consumption. Diabetes induced
a significant increase in the initiation phase of the lipid
peroxidation analyzed as the lag time that accompanies
the oxygen uptake burst. In addition the mitochondrial
fractions of GK peroxidized slowly as compared to the
controls. The observed increase in the lag phase and the
decrease in oxygen consumption, TBARS and
MDA formation are probably due to the higher content
of a-tocopherol in GK diabetic animals. It has been
observed that liver microsomes from vitamin-E deficient
rats peroxidized at a greater rate than control microsomes
[44]. Vitamin E (a-tocopherol) is well established as one
of the most important lipid-soluble, chain reaction-
breaking antioxidants protecting the integrity of lipid
structures in membranes against oxidative damage [45].
Increased levels of vitamin E in liver [12,46] and heart
[46,47] of streptozotocin-treated diabetic rats and in
brain membranes of db/db mice [48] have been reported.
Sukalski et al. [12] suggested that the increased vitamin E
levels associated with diabetes may be due to alterations
in the metabolism and storage of vitamin E. The elevation
of vitamin E content in membranes may be partially
explained by the fact that plasma vitamin E may be
increased by mobilization with lipids from the adipose
tissue and the liver to other tissues [12]. Besides its effects
linked to antioxidative properties, vitamin E has
been shown to reduce protein glycosylation both in vivo
and in vitro [49,50] and to improve insulin action in non-
diabetic and non-insulin-dependent diabetic patients [51]
and b-cell function [52]. Vatassery et al. [37] found that
plasma and platelet vitamin E levels were higher in
patients with types 1 and 2 diabetes as compared to the
control group.
In recent years there has been considerably interest in
the protective role of CoQ against oxidative stress. Besides
its well-established function as a component of the
mitochondrial respiratory chain, in its reduced form
CoQ may function as an antioxidant, protecting mem-
brane phospholipids and serum low-density lipoprotein
from lipid peroxidation by quenching lipid radicals or
lipid peroxidation initiating species and, as recent data
indicate, it also protects mitochondrial membrane pro-
teins and DNA from free radical-induced oxidative
damage [25,26,53]. These effects seem to be independent
of those of exogenous antioxidants, such as vitamin
E, although CoQ can also potentiate the effect of
a-tocopherol by regenerating it from its oxidized form
[54]. Coenzyme Q is endogenously synthesized in most
mammalian cells and organs and its levels in membranes
are regulated, through the mevalonate pathway, by
physiological factors that are related to oxidative activity
of the organism. Evidence that the increase in CoQ
content occurred after the increase in metabolic rate, and
thus free radical production (e.g. during physical
exercise, cold adaptation or thyroid hormone treatment)
suggests that the increase in CoQ may an adaptation to or
a response to, rather than a cause of, increased oxidative
activity [25,54]. Boveris et al. [55] have also shown that
CoQ levels significantly increased in liver mitochondria
isolated from rats made diabetic by pancreatectomy. It is
interesting to note that the increase in CoQ content in
liver mitochondria of GK rats may be related to the in-
creased efficiency of mitochondrial FAD-linked glycerol-
3-phosphate dehydrogenase, the key enzyme in the
glycerol phosphate shuttle, and to an increased efficiency
rate of oxidative metabolism, as a result of the increased
efficiency in the oxidative phosphorylation of diabetic rats
as compared with control animals, features that are
exclusive to the liver [56,57]. This may explain why CoQ
levels increase in diabetes only in the liver and not in
brain mitochondria.
The present results constitute the first evidence for
possible differential metabolism of CoQ in diabetic
animals and augment earlier reports on the higher
content of a-tocopherol in several preparations isolated
from diabetic animals. The simultaneous increase of CoQ
and a-tocopherol in rat liver mitochondria isolated
from GK rats suggests an interaction between CoQ and
a-tocopherol. Sohal and colleagues reported recently that
the recycling of a-tocopherol in mitochondrial mem-
branes is directly dependent of the molar ratios of
a-tocopherol and CoQ [58,59]. In fact, and in contrast to
liver mitochondria, an insufficient amount of CoQ may
explain why the levels of a-tocopherol in brain mitochon-
dria were unchanged in GK diabetic animals. Recent
studies have indicated that the generation of superoxide
anion by submitochondrial particles was inversely related
to their a-tocopherol content and unrelated to CoQ, and
that the antioxidative role of CoQ in mitochondria may
be due to a ‘sparing/regenerating effect’ of CoQ on
a-tocopherol rather than a direct effect as radical
scavenger [58,60–62].
In conclusion, the present findings show that liver
preparations of diabetic GK rats were more resistant to
oxidative stress than those of control rats, supporting the
idea that the liver may be protected from the injury
induced by radical species involved in diabetic complica-
tions. The significant increase in vitamin E and CoQ in
liver of GK rats is consistent with the observed decreased
in the susceptibility to in vitro lipid peroxidation. Since
some of the important biochemical reactions determining
the metabolic disorders observed in diabetes are localized
in liver mitochondria, and the liver is a central organ in
glucose homeostasis, the observed increase in antioxidant
defenses and decreased susceptibility to oxidative stress
in GK liver mitochondria could have developed as a
biochemical response or as an adaptation to metabolic
disturbances associated with type 2 diabetes. The
difference in the antioxidant defense mechanisms in the
brain and liver mitochondrial preparations of moderately
hyperglycemic diabetic GK rats may correspond to a
different adaptive response of the cells to the increased
oxidative damage in diabetes.
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